Subsequent studies could involve administering small-molecule compounds to mice with neuron-specific NFE2L1 knockdown to investigate whether such interventions alleviate neurological diseases (Łuczyńska et al., 2024). The gene discussed is NFE2L1; the disease is nervous system disorder.